Peer-Reviewed Clinical Study Shows Ruby-O® Balance Achieves Triglyceride Response at Lower Omega-3 Dose

The study evaluates how omega-3 delivery architecture influences triglyceride outcomes and omega-3 incorporation in ...

Innovent Biologics: Innovent Dosed First Participant in Phase 3 Clinical Study of IBI354 (Novel HER2 ADC) for First Line Treatment of HER2-positive Breast Cancer

HeriCare-Breast01 (NCT07377643) is a multicenter, randomized, open-label, active-controlled study designed to evaluate the safety and efficacy of IBI354, with or without pertuzumab, compared with the ...

Sharyl Attkisson: New medical journal challenges pharmaceutical influence in scientific publishing

A new medical journal launched by the Independent Medical Alliance aims to counter what its founder describes as ...

Science 37 Becomes First FDA-Inspected Site to Deliver Clinical Trials to Patients’ Homes

MORRISVILLE, NC / ACCESS Newswire / February 12, 2026 / Clinical trials are the research studies required to test the ...
Decrypt

AI Chatbots Giving ‘Dangerous’ Medical Advice, Oxford Study Warns

AI chatbots are fighting to become the next big thing in healthcare, acing standarized tests and offering advice to your medical woes. But a new study published in Nature Medicine has shown that they ...

Hometown Health: Medical studies reveal flu’s impact on heart health and brain training benefits

New medical research reveals connections between the flu and heart disease, highlights infection risks for people with ...

Microfluidic method boosts control and separation of tiny particles—a promising tool for medical research

In nanoscale particle research, precise control and separation have long been a bottleneck in biotechnology. Researchers at ...

Acorn Biolabs Advances Hair Regeneration With First Patients Treated using YOU™ Secretome in Randomized Clinical Study

Randomized, blinded clinical study evaluating injectable autologous hair follicle secretome in patients with androgenic ...
Worcester Business Journal

Southborough clinical research firm names new CEO

Clinical research organization Veristat has a new leader as the Southborough-based firm promoted Kim McLean Boericke to the ...
The Manila Times

Innovent Dosed First Participant in Phase 3 Clinical Study of IBI354 (Novel HER2 ADC) for First Line Treatment of HER2-positive Breast Cancer

Innovent Biologics, Inc. ('Innovent',HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, ...